Jukka Alinikula
PhD, Adjunct professor, Education director of Immudocs
juilal@utu.fi +358 29 450 4577 +358 50 516 7449 Kiinamyllynkatu 10 Turku Office: 7th floor ORCID identifier: https://orcid.org/0000-0001-9926-6439 |
Immunology; B cells; somatic hypermutation; antibody genes; immunopharmacology
InFLAMES Flagship; Somatic hypermutation of the genome
I completed my PhD with Prof. Olli Lassila at the University of Turku, focusing on the transcriptional regulation of B cell and plasma cell development and function through loss-of-function studies. During my postdoctoral research at Yale Immunobiology (USA) with David G. Schatz (2012–2015), I investigated the targeting of somatic hypermutation to immunoglobulin genes.
Shortly thereafter, I established my own research group at the Institute of Biomedicine, University of Turku, Finland. In addition to leading independent research projects, I serve as a university lecturer in immunology and drug development.
Protective immunity requires the production of high-affinity antibody-producing cells. My team and I study how high-affinity antibody production is achieved. While most cells minimize somatic mutations to preserve genome stability and prevent tumorigenesis, immunoglobulin genes in B cell development are actively mutated. For example, germinal center B lymphocytes undergo somatic hypermutation (SHM) of immunoglobulin V regions.
Failure to correctly target these mutations can have severe consequences for genome integrity and is implicated in several forms of cancer, particularly leukemia and lymphoma. My research focuses on investigating the molecular mechanisms by which immunoglobulin enhancers recruit SHM to immunoglobulin genes, as well as the processes that lead to the mis-targeting of mutations to other sites in the genome, including several proto-oncogenes.
To address these questions, we utilize techniques such as reporter assays, library screening, genome manipulation, and whole-genome analysis.
Teaching focus ares:
- Immunology
- Immunopharmacology
I teach accrioss various Bachelor's, Master's, MD, and PhD courses in both English and Finnish. My teaching methods include lectures, case-based learning, journal clubs, mentoring, laboratory courses, thesis supervision, and online courses. The topics I cover span innate and adaptive immunity, immunomodulatory drugs and therapeutic antibodies and proteins. I have completed courses on university pedagogy and have supervised and continue to supervise PhD students. Additionally, I participate in follow-up committees of doctoral students.
- (2024)
- Microbes and InfectionCell
(A1 Refereed original research article in a scientific journal) - (2024)
- Tumour Virus Research
(A1 Refereed original research article in a scientific journal) - Ig Enhancers Increase RNA Polymerase II Stalling at Somatic Hypermutation Target Sequences (2022)
- Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Oncogenic Merkel Cell Polyomavirus T Antigen Truncating Mutations are Mediated by APOBEC3 Activity in Merkel Cell Carcinoma (2022)
- Cancer Research Communications
(A1 Refereed original research article in a scientific journal) - Topologically Associated Domains Delineate Susceptibility to Somatic Hypermutation (2019)
- Cell ReportsScandinavian Journal of Immunology
(A1 Refereed original research article in a scientific journal) - (2019)
- European Journal of ImmunologyEncyclopedia of Life Sciences
(A1 Refereed original research article in a scientific journal) - (2018)
- Scandinavian Journal of ImmunologyEuropean Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Bach2 regulates AID-mediated immunoglobulin gene conversion and somatic hypermutation in DT40 B cells (2017)
- European Journal of Immunology
(A1 Refereed original research article in a scientific journal) - (2016)
- PLoS ONEScandinavian Journal of Immunology
(A1 Refereed original research article in a scientific journal) - IRF4 Deficiency Leads to Altered BCR Signalling Revealed by Enhanced PI3K Pathway, Decreased SHIP Expression and Defected Cytoskeletal Responses (2015)
- Scandinavian Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Super-Enhancer Transcription Converges on AID (2014)
(A2 Refereed review article in a scientific journal ) - Targeting of Somatic Hypermutation by immunoglobulin Enhancer and Enhancer-Like Sequences (2014)
- PLoS Biology
(A1 Refereed original research article in a scientific journal) - A Critical Context-Dependent Role for E Boxes in the Targeting of Somatic Hypermutation (2013)
- Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Alternate pathways for Bcl6-mediated regulation of B cell to plasma cell differentiation (2011)
- European Journal of Immunology
(A1 Refereed original research article in a scientific journal) - Gene interaction network regulates plasma cell differentiation (2011)
(A1 Refereed original research article in a scientific journal) - Bursa of Fabricius (2010)
(D2 Article in a professional compilation book) - Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP (2010)
(A1 Refereed original research article in a scientific journal) - Regulation of B Cell Gene Expression and Function by Ikaros, Helios and Bcl6 (2010) Jukka Alinikula
(G5 Article dissertation ) - Spontaneous acquisition of plasma cell phenotype in DT40 B cells with inactivation of Bcl-6 (2007)
(D3 Article in a professional conference publication) - DT40 mutants: a model to study transcriptional regulation of B cell development and function (2006) Alinikula Jukka, Lassila Olli, Nera Kalle-Pekka
(A2 Refereed review article in a scientific journal )